Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells
Mutagenesis · 01.12.2020 · 35 (5) · 361-371
DOI: 10.1093/mutage/geaa021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mutagenesis, online erschienen am 13.08.2020. Verfasst von Ana Paula Braga Lima und 5 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Ciências Farmacêuticas (CIPHARMA), Universidade Federal de Ouro Preto, Campus Morro do Cruzeiro, Morro do Cruzeiro, Ouro…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Universidade Federal de Ouro Preto, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Abstract (Originalsprache)
The antitumour activity of chrysin have been studied in several types of cancer cells. In urinary bladder cancer, its cytotoxic effects have already demonstrated; however, its mechanism of action is not completely understood and the role of tumour protein p53 (TP53) gene in these effects is unclear. In this study, we investigated the role of chrysin (10, 20, 40, 60 80 and 100 µM) in progression of bladder tumour cells with different status of the TP53 gene and different degrees of tumour (RT4, grade 1, TP53 wild type; 5637, grade 2, TP53 mutated and T24, grade 3, TP53 mutated). Results demonstrated that chrysin inhibited cell proliferation by increasing reactive oxygen species and DNA damage and inhibited cell migration in all cell lines. In TP53 wild-type cells, a sub-G1 apoptotic population was present. In mutated TP53 cells, chrysin caused arrest at the G2/M phase and morphological changes accompanied by downregulation of PLK1, SRC and HOXB3 genes. In addition, in Grade 2 cells, chrysin induced global DNA hypermethylation and, in the highest-grade cells, downregulated c-MYC, FGFR3 and mTOR gene expression. In conclusion, chrysin has antiproliferative and toxicogenetic activity in bladder tumour cells independently of TP53 status; however, the mechanisms of action are dependent on TP53 status.
Autor:innen und Institutionen
- Programa de Pós-graduação em Ciências Farmacêuticas (CIPHARMA), Universidade Federal de Ouro Preto, Campus Morro do Cruzeiro, Morro do Cruzeiro, Ouro Preto, Minas Gerais, Brazil.
- Programa de Pós-graduação em Ciência Biológicas (CBIOL), Universidade Federal de Ouro Preto, Morro do Cruzeiro, Bauxita, Ouro Preto, Minas Gerais, Brazil.
- Departamento de Ciências Biológicas (DECBI), Instituto de Ciências Exatas e Biológicas, Universidade Federal de Ouro Preto, Morro do Cruzeiro, Bauxita, Ouro Preto, Minas Gerais, Brazil.
- Departamento de Análises Clínicas (DEACL), Escola de Farmácia, Universidade Federal de Ouro Preto, Morro do Cruzeiro, Bauxita, Ouro Preto, Minas Gerais, Brazil.
Förderung
- Universidade Federal de Ouro Preto
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Zitieren
APA
Lima, A. P. B., Almeida, T. C., Barros, T. M. B., Rocha, L. C. M., Garcia, C. C. M., & da Silva, G. N. (2020). Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells. Mutagenesis, 35(5), 361-371. https://doi.org/10.1093/mutage/geaa021
Vancouver
Lima APB, Almeida TC, Barros TMB, Rocha LCM, Garcia CCM, da Silva GN. Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells. Mutagenesis. 2020;35(5):361-371. doi:10.1093/mutage/geaa021
BibTeX
@article{Lima2020,
author = {Lima, Ana Paula Braga and Almeida, Tamires Cunha and Barros, Tatiane Martins Barcelos and Rocha, Lorrana Cachuite Mendes and Garcia, Camila Carriao Machado and da Silva, Glenda Nicioli},
title = {Toxicogenetic and antiproliferative effects of chrysin in urinary bladder cancer cells},
journal = {Mutagenesis},
year = {2020},
volume = {35},
number = {5},
pages = {361--371},
doi = {10.1093/mutage/geaa021}
}
EUVIMED